Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...
Chinese Vice-Premier He Lifeng has been urging more investment from the United States to promote a healthy US-China ...
In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, Singapore.
COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...
The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.2 billion with French ...
The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...
IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.
Novavax sells manufacturing facility to Novo Nordisk for $200M, enabling Novavax to advance growth strategy and drive value ...
The "North America Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others" report has been added to ResearchAndMarkets.com's offering.The North American orthobiologics ...
In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...
With the purchase of a plant in the Czech Republic, Novo Nordisk is saying “jak se máš” to hundreds of new employees—and ...
Maze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, ...